In relation to the best method of risk-based PCa screening before biopsy, flexible algorithms according to local resource availability have been proposed, but the essence of all of them is to break the link between elevated PSA and immediate biopsy to reduce unnecessary biopsy procedures and overdiagnosis [27]. The gene discussed is KLK3; the disease is posterior cortical atrophy.